Copyright: ©Author(s) 2026.
World J Transplant. Jun 18, 2026; 16(2): 116999
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.116999
Published online Jun 18, 2026. doi: 10.5500/wjt.v16.i2.116999
Table 1 Description of published cases of adrenal metastasis from hepatocellular carcinoma after liver transplantation
| Ref. | Age/gender | Indication for LT | AFP PreLT (ng/mL) | Child-Pugh | HCC (cm) | Time from LT-AM (meses) | AFP PreAM (ng/mL) | AM size (cm) | Adrenal location | Treatment | Follow up after am treatment | Other comments |
| Castroagudín et al[14] | 51/male | Alcohol + HCC | 2.9 | NA | 4 | 5 | NA | 4.4 | Left | Surgical, open | 43 months, alive without recurrence | Right AM after 8 months of follow-up |
| Mourad et al[4] | 53/male | HCV + HCC | 756 | NA | 3.3 | 24 | 143 | 8 | Left | Surgical, open | NA | |
| Pandey et al[19] | 64/male | HBV + HCC | NA | NA | 15 | 3 | NA | 6 | Left | Surgical, open | 24 months, alive without recurrence | Gemcitabine and 5FU after surgery |
| Rubio et al[2] | 23/male | HBV + HCC | NA | NA | 11 | 36 | NA | 2.7 | Right | Surgical, open | NA | Adriamycin after LT. Everolimus after adrenalectomy |
| Chen et al[10] | 60/male | HBV + HCC | 7812 | B | NA | 39 | 55,8 | 4 | Left | Surgical, Laparoscopic | 30 months, alive without recurrence | Capecitabine and oxaliplatin after LT. Gemcitabine and 5 after adrenalectomy. Lung metastases after 30 months of LT |
| Choi et al[11] | 71/male | HCV + HCC | 87.96 | A | Multiple | 11 | 6,02 | 5 | Left | Surgical, open | 16 months, deceased after recurrence | |
| Ha et al[15] | 56.1/NA | HBV + HCC (6), HCV + HCC (1) | NA | NA | 4/7 Milan criteria | 42.6 | NA | 3.4 | 3 × left, 4 × right | Surgical 6 open and 1 Laparoscopic | OS after 5 years of follow-up: 85.7%. Recurrence after 3 years of follow-up: 28.6% | 7 patients, 5 × living donor LT +, 2 × deceased LT |
| Shimokawa et al[13] | 47/female | HBV + HCC | 2.6 | C | 4 lesions (3, 2, 2 and NA) | 30 | 319.4 | 3 | Left | Surgical, open | 38 months, alive without recurrence | Double liver recurrence (surgery + RF). Bone recurrence. Living donor LT |
| Jalbani et al[5] | 61/male | HCV + HCC | Normal | NA | 3.5 | 15 | 1,0 | 5.5 | Right | Surgical, Laparoscopic | 24 months, alive without recurrence | Everolimus after adrenalectomy |
| Sormaz et al[18] | 55/female | Cryptogenic + HCC | NA | B | 4 T3bN0M0 | 138 | NA | 10 | Right | Surgical, open | 36 months, alive without recurrence | |
| Ince et al[1] | 61/male | HBV + HCC | 187 | B | 25 | 12 | 275 | 4 | Left | Surgical, open + left nephrectomy | 10 months, deceased after lung recurrence | Living donor LT. Lung recurrence after 4 months of adrenalectomy. Sorafenib |
| Mikulic et al[6] | 56/male | Alcohol + HCC | 1.3 | NA | 4.5 | 30 | Normal | 11.5 | Left | Surgical, open | 24 months, alive without recurrence | Bleeding of right AM after 12 months |
| Zeineddine et al[3] | 72/male | HCV + HCC | NA | NA | 4.2 | 60 | 13.8 | 4.1 | Right | SBRT | NA | |
| Kim et al[12] | 49/male | Alcohol + HBV + HCC | 9.3 | NA | 4.7 | 18 | 2.0 | NA | Right | RT + mTOR inhibitor | 53 months, deceased after bone and IH recurrence | Adrenal recurrence after 5 months of follow-up |
| This article | 62/male | HCV + HCC | 29.06 | A | 2.5 and 1.8 | 48 | 42115.26 | 4.2 | Left | Surgical, open | 27 months, alive without recurrence with high AFP | Adrenal recurrence after 14 months treated with surgery. Everolimus/siroilimus |
- Citation: Ramia JM, Franco M, Alcázar C, Carbonell-Morote S, Rubio-García JJ, Rodríguez M, Pascual S, Melgar P, Villodre Tudela C. Adrenal metastasis of hepatocellular carcinoma after liver transplantation: Case report and systematic review of literature. World J Transplant 2026; 16(2): 116999
- URL: https://www.wjgnet.com/2220-3230/full/v16/i2/116999.htm
- DOI: https://dx.doi.org/10.5500/wjt.v16.i2.116999